NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,948,674 | -74.8% | 107,070 | -28.8% | 0.02% | -75.4% |
| Q2 2022 | $7,735,072 | +212.2% | 150,400 | +347.1% | 0.06% | +306.2% |
| Q1 2022 | $2,477,586 | +39.7% | 33,640 | +171.3% | 0.02% | +60.0% |
| Q4 2021 | $1,774,068 | +71.2% | 12,400 | +148.0% | 0.01% | +25.0% |
| Q3 2021 | $1,036,550 | -23.4% | 5,000 | -21.6% | 0.01% | -11.1% |
| Q2 2021 | $1,353,264 | -67.2% | 6,374 | -72.0% | 0.01% | -75.0% |
| Q1 2021 | $4,120,632 | -65.5% | 22,727 | -78.8% | 0.04% | -61.7% |
| Q4 2020 | $11,929,228 | -1.2% | 106,979 | -4.0% | 0.09% | -29.3% |
| Q3 2020 | $12,069,000 | -60.6% | 111,388 | -69.7% | 0.13% | -63.2% |
| Q2 2020 | $30,655,000 | +1402.7% | 367,775 | +144.9% | 0.36% | +1469.6% |
| Q1 2020 | $2,040,000 | – | 150,192 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |